Suvannasankha, A., Tompkins, D., Edwards, D., Petyaykina, K., Crean, C., Fournier, P. G. J., Parker, J., Sandusky, G., Ichikawa, S., Imel, E., & Chirgwin, J. (2015). FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells. Oncotarget, 6(23), 19647-19660. doi: 10.18632/oncotarget.3794. (ID: 19183) ^(E)

Stayrook, K., Mack, J., Cerabona, D., Edwards, D., Bui, H., Niewolna, M., Fournier, P. G. J., Mohammad, K., Waning, D., & Guise, T. (2015). TGFß-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis. BoneKEy Reports, 4(719), 13. doi: 10.1038/bonekey.2015.88. (ID: 19419) ^(E)

Villegas Rivera, G., Roman Pintos, L. M., Cardona Muñoz, E. G., Arias Carvajal, O., Rodriguez Carrizales, A. D., Troyo Sanroman, R., Pacheco Moises, F. P., Moreno Ulloa, A., & Miranda Diaz, A. G. (2015). Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Oxidative Medicine and Cellular Longevity. doi: 10.1155/2015/756294. (ID: 23123) ^(E)

Pimienta Rosales, G., Fok, V., Haslip, M., Nagy, M., Seyedtaghi, T., & Steitz, J. (2015). Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2. PLoS ONE, 1-25. doi: 10.1371/journal.pone.0124638. (ID: 20233) ^(E)

Fournier, P. G. J., Juárez Camacho, P., Jiang, G., Clines, G., Niewolna, M., Kim, H. S., Walton, H., Peng, X., Liu, Y., Mohammad, K., Wells, C., Chirgwin, J., & Guise, T. (2015). The TGF-ß Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone. CANCER CELL, 27(6), 809-821. doi: 10.1016/j.ccell.2015.04.009. (ID: 19179) ^(E)

Beltrán Partida, E., Valdez Salas, B., Escamilla, A., Moreno Ulloa, A., Burtseva, L., Valdez Salas, E., Curiel, M. A., & Nedev, N. R. (2015). The Promotion of Antibacterial Effects of Ti6Al4V Alloy Modified with TiO2 Nanotubes Using a Superoxidized Solution. Journal of Nanomaterials, 2015, 9. doi: 10.1155/2015/818565. (ID: 23119) ^(E)

Fajardo Ramírez, O. R., Ascacio Martínez, J. Á. I., Licea Navarro, A. F., Villela Martinez, L. M., & Barrera Saldaña, H. A. (2015). Technological Evolution in the Development of Therapeutic Antibodies. Revista de Investigación Clínica, 67(3), 158-169. (ID: 20213)

Rios, C., Orozco-Suarez, S., Salgado-Ceballos, H., Mendez-Armenta, M., Nava-Ruiz, C., Santander, I., Baron-Flores, V., Caram Salas, N. L., & Diaz-Ruiz, A. (2015). Anti-Apoptotic Effects of Dapsone After Spinal Cord Injury in Rats. NEUROCHEMICAL RESEARCH, 40(6), 1243-1251. doi: 10.1007/s11064-015-1588-z. (ID: 24266) ^(E)

Espino Solis, G. P., Quintero Hernandez, V., Olvera Rodriguez, A., Juana Calderon, A., Pedraza Escalona, M., Licea Navarro, A. F., Flores Romo, L., & Possani Postay, L. D. (2015). Novel monoclonal antibody against alphaX subunit from horse CD11c/CD18 integrin. Veterinary Immunology and Immunopathology, 164(3-4), 220-226. doi: 10.1016/j.vetimm.2015.02.002. (ID: 19027)

Barnett, C., Moreno Ulloa, A., Shiva, S., Ramirez Sanchez, I., Taub, P., Yongxuan, S., Ceballos, G., Dugar, S., Schreiner, G., & Villarreal, F. (2015). Pharmacokinetic, partial pharmacodynamic and initial safety analysis of (-)-Epicatechin in healthy volunteers. Food & Function, 6(3), 824-833. doi: 10.1039/C4FO00596A. (ID: 23110) ^(E)